Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab<sup>®</sup>-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery

Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab<sup>®</sup>-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery

Glioblastoma (GBM) is one of the most aggressive tumors and its 5-year survival is approximately 5%. Fluorescence-guided surgery (FGS) improves the extent of resection and leads to better prognosis. Molecular near-infrared (NIR) imaging appears to outperform conventional FGS, however, novel molecula...

Full description

Bibliographic Details
Main Authors: Dmitry M. Polikarpov, Douglas H. Campbell, Lucinda S. McRobb, Jiehua Wu, Maria E. Lund, Yanling Lu, Sergey M. Deyev, Andrew S. Davidson, Bradley J. Walsh, Andrei V. Zvyagin, David A. Gillatt
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
brain neoplasm
fluorescence-guided surgery
glypican-1
IRDye800CW
Miltuximab
monoclonal antibodies
Online Access:https://www.mdpi.com/2072-6694/12/4/984

Similar Items

Similar Items